Our aim was to enhance IL-12-mediated induction of the antitumor immune response through DCN-mediated downregulation of TGF-β activity in a weakly immunogenic murine 4T1 orthotopic breast cancer model that mimics clinical tumors. Here, TGFB1 is linked to breast carcinoma.